EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer

Neeraj Agarwal, Tian Zhang, Eleni Efstathiou, Nicolas Sayegh, Arne Engelsberg, Fred Saad, Karim Fizazi

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.113249 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Neeraj Agarwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerases, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) PolymerasesProstatic Neoplasms, Castration-ResistantMaleHumansReceptors, AndrogenAndrogensPoly(ADP-ribose) Polymerase InhibitorsAndrogen Receptor AntagonistsAdenosine Diphosphate RiboseBiologyRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Androgen receptorCombination therapyPARPPathogenesisProstate cancer

Substanzen

Poly(ADP-ribose) PolymerasesReceptors, AndrogenAndrogensPoly(ADP-ribose) Polymerase InhibitorsAndrogen Receptor AntagonistsAdenosine Diphosphate Ribose

Autor:innen und Institutionen

  • Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: neeraj.agarwal@hci.utah.edu.
  • Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
  • Houston Methodist Cancer Center, Houston, TX, USA.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Pfizer Oncology Global Medical Affairs, Berlin, Germany.
  • Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Québec, Canada.

Zitieren

APA

Agarwal, N., Zhang, T., Efstathiou, E., Sayegh, N., Engelsberg, A., Saad, F., & Fizazi, K. (2023). The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113249

Vancouver

Agarwal N, Zhang T, Efstathiou E, Sayegh N, Engelsberg A, Saad F, et al. The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113249

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Neeraj and Zhang, Tian and Efstathiou, Eleni and Sayegh, Nicolas and Engelsberg, Arne and Saad, Fred and Fizazi, Karim},
  title = {The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.113249}
}
Kostenlos starten →